The treatment of choice for severe malaria is quinine. However, a gradual progression of
resistance to quinine has become a concern in parts of the world. Artemisinin-related …

A randomised trial was conducted in adults and children (> 1 year old) with acute falciparum
malaria in Western Myanmar to compare the operational effectiveness of 4 different …

Eurosurveillance | Intravenous artesunate recommended for patients with severe malaria:
position statement from TropNetEurop 1887 Other sites: ECDC European Antibiotic …

Until recent years, public interest and political investment in malaria prevention, control, and
research have been stagnant. The global malaria agenda is now experiencing an …

Parasite resistance to conventional antimalarial medicines has led, in recent years, to a
dramatic shift in malaria treatment. Sixty-seven countries with endemic Plasmodium …

Severe malaria is a medical emergency. It is a major cause of preventable childhood death
in tropical countries. Severe malaria justifies considerable global investment in malaria …

The therapeutic efficacy and toxicity of artesunate (2mg/kg/day for five days, then 1
mg/kg/day for two days: total 12 mg/kg) was compared with that of artemether (4 mg/kg …

Objective To test the hypothesis that artesunate plus amodiaquine (ASAQ) is as effective as
artemether–lumefantrine (AL) in the treatment of acute uncomplicated malaria in Nigerian …

Background Appropriate treatment of life-threatening Plasmodium falciparum malaria
requires in-patient care. Although the proportion of severe cases accessing in-patient care in …

Malaria remains a leading cause of underfive morbidity and mortality in sub‐Saharan Africa.
Effective case management is a strategy recommended by the World Health Organization for …